Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin

NCT02667925 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Because of the obsolescence of the study

Conditions

Ovarian Cancer

Interventions

DRUG: Intraperitoneal cisplatin with nanocis

Sponsor

Centre Jean Perrin